Novartis Pharmaceuticals Corporation et al v. Zenara Pharma Private Limited et al

Docket(#9) Report to the Commissioner of Patents and Trademarks.(lnb) (Entered: 07/01/2025)

Docket(#8) ORDER re #7 Notice of Voluntary Dismissal filed by Novartis AG, Novartis Pharmaceuticals Corporation, ***Civil Case Terminated. Signed by Judge Gregory B. Williams on 7/1/2025. (lnb) (Entered: 07/01/2025)

Docket(#7) NOTICE of Voluntary Dismissal by Novartis AG, Novartis Pharmaceuticals Corporation (Joyce, Alexandra) (Entered: 06/30/2025)

DocketCase Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (alb) (Entered: 05/28/2025)

Docket(#6) Summons Issued as to Biophore India Pharmaceuticals Private Limited on 5/23/2025; Zenara Pharma Private Limited on 5/23/2025. (Attachments: #1 Summons Issued)(oam) (Entered: 05/23/2025)

Docket(#5) Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis AG, Novartis Pharmaceuticals Corporation. (oam) (Entered: 05/23/2025)

Docket(#4) Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,828,430. (oam) (Entered: 05/23/2025)

Docket(#3) Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: See Attached. Date of Expiration of Patent: 08/01/2027.Thirty Month Stay Deadline: No Earlier than 10/11/2027. (oam) Modified on 5/27/2025 (nms). (Entered: 05/23/2025)

Docket(#2) Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) (Entered: 05/23/2025)

Docket(#1) COMPLAINT against Biophore India Pharmaceuticals Private Limited, Zenara Pharma Private Limited (Filing fee $ 405, receipt number ADEDC-4694823) - filed by Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(oam) (Entered: 05/23/2025)